Clinical trial
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
NCT00386906 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00386906 |
|---|---|
| Title | Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma |
| Official title | Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Eye Disease, Melanoma |
| Intervention type | Procedure |
| Interventions | Sentinel Lymph Node Mapping and Biopsy |
| Enrollment | 38 |
| Start date | May 30, 2000 |
| Primary completion | Sep 28, 2023 |
| Completion | Sep 28, 2023 |
| First posted | Oct 12, 2006 |
| Last update posted | May 7, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: